In the global fight against HIV, the "holy grail" has long been the quest for a prevention method that is highly effective, discreet, and easy to maintain.
The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.
The U.S. Food and Drug Administration (FDA) recently approved a groundbreaking new option for preventing HIV, the virus that causes AIDS. The injectable drug lenacapavir was approved in June and is ...
Briefly on MSN
South Africa to roll out Lenacapavir HIV prevention injection in 2024, targeting key populations
South Africa will launch Lenacapavir, a six-month HIV prevention injection, in six provinces, targeting all HIV-negative individuals to curb new infections.
Health and Me on MSN
Zimbabwe among the first African countries to roll out breakthrough HIV injections
Zimbabwe has launched twice yearly lenacapavir HIV prevention injections, offering near total protection. The country hopes to curb infections and stigma driven adherence issues, though high cost and ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new long-lasting prophylactic treatment for HIV-1 that is administered once every 6 months. Lenacapavir (Yeytuo, Gilead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results